BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
BBOT Stock Analysis: Buy, Sell, or Hold?
$2.35
-0.21 (-8.20%)
▼
5d:
+8.29%
30d:
-19.1%
90d:
-74.06%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$2.33 – $3.17
Position: OVERSOLD
Forward P/E & Valuation
-1.0x
Next 12M consensus est.
Wall Street Target
$23.00
+878.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.98 / $2.74
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BBOT shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When BBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BBOT is currently trading at $2.35, which is considered oversold relative to its 30-day fair value range of $2.33 to $3.17.
Technical Outlook: Technically, BBOT is in a strong downtrend. Immediate support is located at $1.98, while resistance sits at $2.74. Short-term momentum is weak, with the stock down 8.2% recently.
Market Sentiment: BBOT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $23.00 (+878.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BBOT is in a strong downtrend. Immediate support is located at $1.98, while resistance sits at $2.74. Short-term momentum is weak, with the stock down 8.2% recently.
Market Sentiment: BBOT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $23.00 (+878.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.33 -
$3.17
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$2.33 -
$3.17
Current vs Trading Range
OVERSOLD
Support Level
$1.98
Resistance Level
$2.74
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.2%)
- BULLISH: Trading 878.7% below Wall St target ($23.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.95
Wall Street Target
$23.00
(+878.7%)
Share BBOT Analysis
Share this live BBOT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BBOT)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows bullish sentiment towards $BBOT with mention of KPTI. No recent Yahoo Finance news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:56 PM ET
Data refreshes hourly during market hours. Next update: 9:56 PM
Data refreshes hourly during market hours. Next update: 9:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BBOT Research Pages
